At this year’s Consumer Electronics Show (CES), I had the opportunity to join an important conversation on the future of longevity technology during a panel titled “Longevity Tech: Hype, Hope, or Here to Stay?”, moderated by Michael Clinton.
Why was longevity discussed at CES?
Longevity appeared at CES because aging, AI, and consumer health technologies are converging, making proactive health and lifespan optimization scalable.
CES is a signal event. When longevity takes the main stage at the world’s largest technology conference, it confirms something many of us in medicine have felt for years: longevity is no longer niche — it is entering the mainstream.
Below are my key takeaways from the discussion, and what they mean for patients, physicians, and the future of healthcare.
Longevity Has Officially Gone Mainstream
Longevity is no longer limited to elite clinics or fringe biohacking communities. Advances in science, medicine, AI, diagnostics, and consumer technology are converging rapidly. Together, they are creating a new category of care focused not just on lifespan, but on healthspan, function, and quality of life.
While definitions of longevity still vary — prevention, optimization, disease interception, or aging reversal — the direction is clear:
longevity is becoming scalable, measurable, and actionable.
This shift is driven by:
-
Better data collection (labs, imaging, wearables, multi-omics)
-
Patient empowerment and health literacy
-
Technology that enables continuous, personalized monitoring
-
A growing demand for proactive rather than reactive healthcare
We Are in the “Influencer Phase” of Longevity Tech
One of the most important points I shared on the panel is that today’s longevity landscape is in what I call its “influencer phase.”
There are now hundreds of longevity tools on the market:
-
Biomarker panels
-
Full-body imaging
-
Wearables and rings
-
At-home testing kits
-
AI-driven health dashboards
Some of these tools are excellent. Many are not.
For consumers — and even for physicians — it has become increasingly difficult to distinguish signal from noise, evidence from marketing, and clinical value from hype.
This creates a critical need for:
-
Medical oversight
-
Evidence-based standards
-
Trusted frameworks for evaluation
-
Physicians trained in longevity medicine
Technology alone is not enough. Clinical judgment remains the gatekeeper of trust.
Scaling Longevity Care Will Require AI
Longevity medicine faces a fundamental scaling problem.
In the United States alone, truly democratizing longevity care would require training hundreds of thousands of physicians. That is not realistic in the short term.
As highlighted by Rafid Fadul, the future depends on AI and machine learning augmenting — not replacing — physicians.
AI will be essential for:
-
Longitudinal data analysis across years of labs and wearables
-
Early signal detection in aging trajectories
-
Clinical decision support
-
Reducing physician cognitive load and burnout
While many workforce-support tools are still early, they will mature quickly. The winners will be systems that preserve human judgment while increasing precision and reach.
Where Longevity Technology Is Heading Next
The panel also explored where the next major breakthroughs will occur:
-
Rafid Fadul:
Decision-support tools integrated seamlessly into daily life, not just clinics. -
William Kapp:
A deeper focus on the immune system, which may prove more central to aging than genomics alone. -
Marina Pavlovic Rivas:
Real-time visibility into biological processes, enabling faster feedback loops and adaptive interventions. -
My perspective:
The rise of personal longevity assistants and active self-care.
Individuals will no longer be passive recipients of care — they will become “longevity architects,” actively designing their health trajectories with the support of physicians and intelligent systems.
From Passive Patients to Longevity Architects
This is perhaps the most important shift of all.
The future of longevity medicine is not about more tests or more data alone. It is about agency.
Patients will increasingly:
-
Understand their biology
-
Track their trajectories over time
-
Make informed lifestyle and medical decisions
-
Partner with physicians, not defer blindly
Longevity technology should empower people to participate in their own care, while doctors remain the trusted navigators of complexity, ethics, and context.
Final Thought
CES made one thing clear:
Longevity technology is here to stay — but its impact will depend on how wisely we integrate it into medicine.
The future will not be built by gadgets alone. It will be built by thoughtful physicians, responsible technology, and empowered individuals working together.
That is the future I am committed to helping shape.
— Dr. David Luu
Cardiac Surgeon | Longevity Architect | Founder, Longevity Docs